XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Nov. 01, 2020
Nov. 03, 2019
Cash flows from operating activities:    
Net (loss) income $ (349) $ 3,366
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation 3,538 3,893
Amortization 235 353
Stock-based compensation 474 467
Deferred income taxes 4,419 53
Gain on disposal of equipment   (93)
Realized loss on short-term investments available for sale 6  
(Income) loss from investment in unconsolidated joint venture (167) 3
Foreign currency exchange loss (gain) 723 (106)
Changes in assets and liabilities:    
Accounts receivable (7,663) (835)
Inventories 602 (4,797)
Other current assets (1,175) (31)
Other assets (40) 133
Accounts payable – trade 14,156 3,564
Deferred revenue (127) (24)
Accrued expenses and deferred compensation 6,019 1,620
Accrued restructuring costs   (89)
Income taxes 2,052 770
Net cash provided by operating activities 22,703 8,247
Cash flows from investing activities:    
Capital expenditures (2,041) (2,410)
Proceeds from the sale of equipment 12 363
Investment in unconsolidated joint venture (90)  
Proceeds from the maturity of short-term investments (Held to Maturity) 1,800 5,000
Purchase of short-term and long-term investments (Held to Maturity) (1,245)  
Purchase of short-term investments (Available for Sale) (5,010)  
Proceeds from the sale of short-term investments (Available for Sale) 455  
Proceeds from the sale of long-term investments (rabbi trust) 77  
Purchase of long-term investments (rabbi trust) (257) (479)
Net cash (used in) provided by investing activities (6,299) 2,474
Cash flows from financing activities:    
Payments associated with lines of credit (30,772)  
Payments associated with Paycheck Protection Program Loan (7,606)  
Dividends paid (2,583) (2,482)
Cash paid for acquisition of business   (1,532)
Proceeds from subordinated loan payable associated with the noncontrolling interest of discontinued operation   250
Capital contribution from noncontrolling interest associated with discontinued operation   360
Common stock surrendered for withholding taxes payable (25) (51)
Payments of debt issuance costs (15)  
Net cash used in financing activities (41,001) (3,455)
Effect of exchange rate changes on cash and cash equivalents 95 (91)
(Decrease) increase in cash and cash equivalents (24,502) 7,175
Cash and cash equivalents at beginning of period 69,790 40,008
Cash and cash equivalents at end of period [1] $ 45,288 $ 47,183
[1] As of November 3, 2019, cash and cash equivalents totaled $47.2 million, of which $47.0 million and $228,000 were classified as (i) cash and cash equivalents and (ii) within current assets – discontinued operation, respectively, in the accompanying Consolidated Balance Sheets.